The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive Review
Toxins · 14.02.2025 · 17 (2) · 91
DOI: 10.3390/toxins17020091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 14.02.2025. Verfasst von Martina Ferrillo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dentistry Unit, Department of Health Sciences, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy. Hauptthemen laut MEDLINE: Hypertrophy, Masseter Muscle, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Masticatory muscle hypertrophy (MMH) is a rare clinical phenomenon of uncertain etiology, characterized by a soft swelling near the angle of the jaw. This abnormal enlargement of the masseter muscle can alter the facial profile, leading to aesthetic concerns. Moreover, MMH may also have significant functional repercussions, including pain in the masseter region, often associated with temporomandibular disorders, fatigue, and discomfort during mastication. Non-conservative approaches offer an effective and minimally invasive solution by inducing localized muscle relaxation and reducing hypertrophy. Botulinum neurotoxin type A (BoNT/A) represents a therapeutic option for managing MMH, considering that injections can effectively reduce the masseter muscle volume, improving both facial aesthetics and related symptoms. Currently, the standard non-surgical management of MMH is BoNT/A injections, although consensus on the average dosage has not been definitely reached; on the other hand, there are data available in the literature about the injection technique of BoNT/A for lower face contouring. Therefore, the present comprehensive review aimed at exploring in detail the role of BoNT/A in the treatment of masseter muscle hypertrophy, describing its mechanism of action, the administration protocols, the clinical effects, and any side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dentistry Unit, Department of Health Sciences, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy.
- Private Practice, 10121 Turin, Italy.
- Unità Spinale Unipolare, Azienda Ospedaliera per le Emergenze Cannizzaro, 98102 Catania, Italy.
- Physical Medicine and Rehabilitation Unit, Department of Neurosciences, ASST Carlo Poma, 46100 Mantova, Italy.
- Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800 Prague, Czech Republic.
- Private Practice, 90142 Palermo, Italy.
ORCID-Profile: Martina Ferrillo, Loredana Raciti, Dario Calafiore, Michele Vecchio, Umile Giuseppe Longo, Luigi Losco, Alessandro de Sire
Zitieren
APA
Ferrillo, M., Sommadossi, E., Raciti, L., Calafiore, D., Mezian, K., Tarantino, V., Vecchio, M., Longo, U. G., Losco, L., & de Sire, A. (2025). The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive Review. Toxins, 17(2), 91. https://doi.org/10.3390/toxins17020091
Vancouver
Ferrillo M, Sommadossi E, Raciti L, Calafiore D, Mezian K, Tarantino V, et al. The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive Review. Toxins. 2025;17(2):91. doi:10.3390/toxins17020091
BibTeX
@article{Ferrillo2025,
author = {Ferrillo, Martina and Sommadossi, Eleonora and Raciti, Loredana and Calafiore, Dario and Mezian, Kamal and Tarantino, Valeria and Vecchio, Michele and Longo, Umile Giuseppe and Losco, Luigi and de Sire, Alessandro},
title = {The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive Review},
journal = {Toxins},
year = {2025},
volume = {17},
number = {2},
pages = {91},
doi = {10.3390/toxins17020091}
}
EUVIMED